nathalie_moll

EFPIA names new first female Director General Nathalie Moll

pharmafile | February 24, 2017 | News story | Business Services, Medical Communications, Sales and Marketing EFPIA, appointment 

Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as its new Director General.

Moll currently serves as the Secretary General of the European Association for Bioindustries (EuropaBio), a position she has held for six years, and has also served the European Commission and the Italian Biotech Industry Association.

She is due to step into the role in April this year, when she will become the company’s first ever female Director General. Eric Cornut, who stepped in to carry the vacancy left by Richard Bergström last year, will fill the role on an interim basis until that time.

Joe Jimenez, Novartis CEO and President of EFPIA commented on Moll’s appointment: “Nathalie has an excellent track record of leadership and engagement across the life science sector. We are confident she is the right person to lead EFPIA, working with stakeholders to address the challenges faced by healthcare systems in Europe.” 

Moll herself remarked: “I am delighted to be joining EFPIA at a time when pharmaceutical innovation is having such a dramatic effect on the lives of patients across Europe. I look forward to working with EFPIA Members, staff and the wider research, healthcare and policy community to foster an environment that supports continued innovation and drives better outcomes for patients.”

Matt Fellows

Related Content

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

funk

Lonza CEO to step down in 2020

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …

Latest content